Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025

NHS England

This public procurement record has 2 releases in its history.

Award

24 Jul 2025 at 09:22

Award Notice
Tender

10 Feb 2025 at 11:08

Tender Notice
Summary of the contracting process

The NHS Framework Agreement for Branded Medicines, focusing on Tranche A for London and the South of England, along with a national contract for Adult Influenza, represents a significant procurement exercise managed by NHS England. This process, initiated through the open procedure, commenced with tenders and culminated in awards for both lots under the frameworks. The Tranche A framework agreement is set for the period of 1 September 2025 to 31 August 2027, and the Adult Influenza contract spans up to 31 August 2026, with potential extensions at NHS England's discretion. This procurement falls under the Pharmaceutical Products category (CPV 33600000) and focuses on the supply of goods in the UK. The contract award phase, following completion of the tender stage, features numerous active suppliers, including Roche Products Ltd, Amgen Ltd, and AstraZeneca, among others. Key dates included the tender period ending on 18 March 2025, and the contracts were signed on 25 June 2025.

This framework agreement provides extensive business growth opportunities within the pharmaceutical industry, particularly for suppliers of branded medicines and vaccines. The engagement of several large pharmaceutical firms highlights the competitive nature of this sector, though SMEs also have a viable pathway, given the number of SME bids submitted. Companies well-suited to compete in this procurement process are those with a robust supply chain in the UK, capable of meeting both the regional and national healthcare needs—as laid out by NHS England’s far-reaching plans. Participating in such frameworks not only supports the business growth of these companies through significant contract values, like the overall agreement value of £616.714 million, but also fosters long-term relationships with a major buyer in the healthcare sector. Potential bidders are encouraged to review tender documents and procurement specifics through the designated eTendering portal.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025

Notice Description

NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025<br/>CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines - Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027<br/>CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines - Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026

Lot Information

Lot 1 - CM/PHR/24/5718/01 - Tranche A for London and South of England

Please check this box if you have offered against Lot 1 of this Project. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Options: With an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Lot 2 - CM/PHR/24/5718/02 - National Adult Influenza

Please check this box if you have offered against Lot 2 of this Project. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Options: With an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04dd23
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/042580-2025
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£616,714,000 £100M-£1B
Lots Value
£616,704,000 £100M-£1B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
24 Jul 20251 years ago
Submission Deadline
18 Mar 2025Expired
Future Notice Date
Not specified
Award Date
25 Jun 20251 years ago
Contract Period
1 Sep 2025 - 31 Aug 2026 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
SE1 8UG
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
Not specified
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Supplier Information

Number of Suppliers
28
Supplier Names

Accord-UK Ltd

Amgen Ltd

AstraZeneca

Aventis Pharma ltd t/a Sanofi

Bayer Plc

Biogen

CST Pharma Limited

Chugai Pharma UK Ltd

Dr.Reddy's Laboratories (UK) Limited

Eli Lilly and Company Ltd

Gedeon Richter UK Ltd

GlaxoSmithKline UK Limited

Janssen-Cilag Ltd

Manx Healthcare Ltd

Merck Serono Limited

Mylan

Napp Pharmaceuticals Ltd

Novo Nordisk

Orifarm UK

Pfizer Ltd

Pharmacosmos UK Ltd

Roche Products Ltd

Sandoz Ltd

Seqirus UK Limited

Sun Pharma UK Ltd

Teva UK Limited

Thornton and Ross Ltd

Vifor Pharma UK Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...